Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

TESORIERE, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.427
EU - Europa 2.057
AS - Asia 557
AF - Africa 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.419
IT - Italia 606
FI - Finlandia 472
CN - Cina 393
UA - Ucraina 357
IE - Irlanda 167
DE - Germania 114
SG - Singapore 85
GB - Regno Unito 80
SE - Svezia 73
RU - Federazione Russa 43
RO - Romania 37
FR - Francia 32
IR - Iran 22
BE - Belgio 19
KR - Corea 15
PL - Polonia 11
NL - Olanda 10
CI - Costa d'Avorio 9
IN - India 9
TR - Turchia 9
CH - Svizzera 8
PK - Pakistan 8
ES - Italia 6
CA - Canada 5
GR - Grecia 5
AT - Austria 4
BG - Bulgaria 4
JP - Giappone 4
PT - Portogallo 4
EU - Europa 3
NZ - Nuova Zelanda 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CL - Cile 2
CO - Colombia 2
HK - Hong Kong 2
ID - Indonesia 2
MT - Malta 2
MX - Messico 2
BH - Bahrain 1
EC - Ecuador 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
ME - Montenegro 1
NP - Nepal 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.063
Salva come PNG Salva come JPEG
Città #
Fairfield 409
Chandler 318
Ashburn 279
Woodbridge 272
Houston 266
Wilmington 212
Jacksonville 202
Seattle 168
Ann Arbor 155
Dublin 153
Palermo 132
Cambridge 119
Medford 103
Nanjing 87
Des Moines 81
Princeton 63
Singapore 57
Beijing 47
Tulsa 47
New York 44
Dearborn 42
Boardman 35
Jinan 33
Changsha 32
Altamura 30
Lawrence 25
Hebei 24
Shenyang 24
Nanchang 23
San Diego 23
Brussels 19
Jiaxing 17
Tianjin 17
Santa Clara 16
Verona 16
Guangzhou 15
Bremen 13
Milan 13
Menlo Park 12
Düsseldorf 11
Napoli 11
Hangzhou 10
Kraków 10
Ludwigshafen am Rhein 10
Venice 10
Zhengzhou 10
Abidjan 9
Seoul 9
Frankfurt 8
London 8
Saint Petersburg 8
Tehran 8
Izmir 7
Rome 7
Lanzhou 6
Monreale 6
Ningbo 6
Redwood City 6
Seongnam 6
Taiyuan 6
Atlanta 5
Faisalabad 5
Haikou 5
Kunming 5
Los Angeles 5
Madrid 5
San Mateo 5
Taizhou 5
Amsterdam 4
Chicago 4
Edinburgh 4
Fuzhou 4
Helsinki 4
Kilburn 4
Mazara Del Vallo 4
Messina 4
Piscataway 4
San Jose 4
San Paolo di Civitate 4
Washington 4
Agrigento 3
Chengdu 3
Forest City 3
Kumar 3
Latina 3
Norwalk 3
Norwich 3
Parma 3
Phoenix 3
Pisa 3
Sciacca 3
Siena 3
Sofia 3
Tappahannock 3
Adliswil 2
Altofonte 2
Andover 2
Auburn Hills 2
Auckland 2
Berlin 2
Totale 3.957
Salva come PNG Salva come JPEG
Nome #
THE APOPTOTIC EFFECT INDUCED IN HepG2 CELLS BY INHIBITORS OF HISTONE DEACETYLASES IS CORRELATED WITH ACETYLATION OF p53 AND HISTONES. 336
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis 225
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. 171
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells 161
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. 153
Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells. 152
The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells. 150
JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways 149
Retinoblastoma: History of His Identification, Characterization and Treatment 149
Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL. 148
Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. 148
Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. 140
Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. 140
Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). 137
Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. 134
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells 133
Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt. 130
Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors. 129
The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation 122
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. 115
3AB-OS, a new human pluripotent cancer stem cell: properties and expectations for practical applications. 114
Composizioni farmaceutiche per il trattamento di tumori epatici 111
Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8. 109
Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231 106
Differentiation of human osteosarcoma 3AB-OS stem-like cells in derivatives of the three primary germ layers as an useful in vitro model to develop several purposes 105
Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. 102
Parthenolide sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis 99
WIN55,212-2, a synthetic agonist of cannabinoid receptors, sensitizes tumor cells to TRAIL-induced apoptosis. 97
Histone deacetylase inhibitors in cancer therapy: Biological and clinical implications. 97
The HDAC inhibitor SAHA synergistically stimulates the cytotoxic effect induced by Parthenolide in MDA-MB231 cells 87
The synthetic cannabinoid WIN sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by activating p8/CHOP/DR5 axis. 86
THE ROLE OF THE EXTRINSIC PATHWAY OF APOPTOSIS IN THE EFFECT INDUCED BY SAHA IN HUMAN HEPATOMA CELLS. 84
Parthenolide induces caspase-independent cell death in osteosarcoma, melanoma and breast cancer cells through the induction of oxidative stress. 84
THE APOPTOTIC EFFECT EXERTED IN HUMAN HEPATOMA CELLS BY THE INHIBITOR OF HISTONE DEACETYLASE SAHA EITHER ALONE OR IN COMBINATION WITH BORTEZOMIB. 82
Histone deacetylase inhibitors: Epigenetic drugs acting by pleiotropic apoptotic mechanism in tumor cells and highly potent in combination with other antitumor agents. 80
The transcription factor CHOP is critical for WIN-mediated DR5 up-regulation in apoptosis induced by WIN/TRAIL co-treatment in hepatoma cells 76
The mechanism by which histone deacetylase inhibitors sensitize hepatoma and colon cancer cells to TRAIL-induced apoptosis 76
COINVOLGIMENTO DELLO STRESS DEL RETICOLO E DEL PROCESSO AUTOFAGICO NELL’APOPTOSI INDOTTA DAL CANNABINOIDE SINTETICO WIN IN CELLULE DI EPATOMA UMANO IN COLTURA 76
HISTONE DEACETYLASE INHIBITORS SENSITIZE HEPATOMA CELLS TO TRAIL_INDUCED APOPTOSIS 74
Okadaic acid-Parthenolide combination at subtoxic doses induces potent synergistic apoptotic effects in human retinoblastoma Y79 cells by upregulating PTEN. 72
The cytotoxic effect exerted by parthenolide and DMAPT on breast cancer stem-like cells 72
Synergistic interaction between Parthenolide and TRAIL induces apoptosis in human hepatocarcinoma cells. 70
The cannabinoid WIN induces DR5 receptor expression in hepatoma cells sensitizing them to TRAIL signal 69
Quaderni del Dottorato di Ricerca in Oncobiologia Sperimentale: Tecniche e Procedure di Ricerca 68
The proteasome inhibitor bortezomib in programmed cell death and cancer therapy 67
Degradation of IkBalfa during apoptosis induced by proteasome inhibitors in hepatoma cells. 66
Role of the acetylation of p53 and histones in SAHA-induced apoptosis in human hepatoma HepG2 cells. 66
Synergistic apoptotic effect in HepG2 cells between bortezomib and hystone deacetylase inhibitors 65
New perspectives in tumor therapy: molecular aspects, 2006 64
APOPTOTIC EFFECTS INDUCED BY ANANDAMIDE IN HEPATIC CELLS. 64
JNK AND AP-1 MEDIATE APOPTOSIS INDUCED BY BORTEZOMIB IN HEPATOMA HEPG2 CELLS. 63
SYNERGISTIC APOPTOTIC INTERACTION BETWEEN THE HDAC INHIBITOR SAHA AND THE PROTEASOME INHIBITOR BORTEZOMIB IN HUMAN HEPATOMA CELLS. 63
Il partenolide sensibilizza le cellule di epatocarcinoma all'apoptosi indotta da TRAIL 62
Proteasome inhibitor Velcade induces apoptosis in hepatoma HepG2 cells stimulating both the extrinsic and the intrinsic apoptotic pathways. 56
The synergistic effect exerted by the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide on triple negative breast canc er cells 56
Synergistic effects induced by combinations of the synthetic cannabinoid WIN55,212-2 and the death receptor ligand TRAIL in hepatoma HepG2 cells. 55
Synergistic effect of the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide in triple negative breast cancer cells. 54
Role of PPARγ in apoptosis induced by cannabinoids in hepatoma HepG2 cells. 53
The involvement of the c-Jun/JNK/AP-1 pathway and HSPs in apoptosis induced by the proteasome inhibitor PS-341 (Velcade) in human hepatoma cells. 53
Differentiative pathway induced by 3-aminobenzamide in MG-63 human osteosarcoma cells. 51
SAHA induces acetylation of p53 and histones in human hepatoma HepG2 cells 51
Janus-Faced role of microRNA let-7d in osteosarcoma 3AB-OS cancer stem cells 51
THE CANNABINOID AGONIST WIN55,212-2 INDUCES APOPTOSIS IN HUMAN HEPATOMA CELLS. 49
Totale 6.327
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.149 0 0 83 86 154 168 157 77 149 70 137 68
2020/2021833 35 77 66 107 75 36 72 38 84 72 89 82
2021/2022643 39 156 13 18 10 15 20 22 98 98 24 130
2022/2023885 107 113 18 110 97 153 65 66 96 2 48 10
2023/2024397 20 65 24 47 31 85 25 34 6 3 9 48
2024/2025106 20 86 0 0 0 0 0 0 0 0 0 0
Totale 6.327